PEGylated cerium oxide nanoparticles alleviate osteoarthritis progression by inhibiting chondrocyte ferroptosis and maintaining cartilage homeostasis
European Journal of Pharmacology · 2026
DOI: 10.1016/j.ejphar.2026.178563 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Huajie Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Hauptthemen laut MEDLINE: Cerium, Chondrocytes, Osteoarthritis, Nanoparticles. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by disruption of articular cartilage homeostasis, with ferroptosis of chondrocytes playing a crucial role. Cerium oxide nanoparticles (CeONPs), a class of inorganic nanozymes, exhibit potent antioxidant and anti-inflammatory properties. However, their effects on OA chondrocytes remain poorly understood. METHODS: mPEG2k-DSPE was employed to facilitate the transfer of CeONPs into the aqueous phase, resulting in PEG-CeONPs. Primary chondrocytes were isolated and subjected to erastin treatment to induce ferroptosis. The impact of PEG-CeONPs on oxidative stress, Fe2+ concentrations, mitochondrial dysfunction, ferroptosis-associated proteins, and OA-related catabolic phenotypes was evaluated. Additionally, the involvement of NRF2 in ferroptosis and its chondroprotective effects were investigated using NRF2-siRNA. An experimental OA model was established in rats through anterior cruciate ligament transection. RESULTS: Our study demonstrated that PEG-CeONPs attenuated erastin-induced cytotoxicity and reduced oxidative stress in chondrocytes. Moreover, PEG-CeONPs inhibited erastin-induced ferroptosis and promoted collagen matrix synthesis and secretion. The protective effects of PEG-CeONPs were mediated by the NRF2 pathway, as NRF2 silencing via siRNA significantly diminished the anti-ferroptosis and chondroprotective effects of PEG-CeONPs in vitro. These findings were further validated in OA rat models, where PEG-CeONPs treatment led to a reduction in ferroptosis-related gene expression and significantly alleviated cartilage degradation. CONCLUSIONS: This study elucidates the previously unexplored relationship between PEG-CeONPs and ferroptosis in OA chondrocytes. PEG-CeONPs demonstrate anti-ferroptosis and chondroprotective effects by activating the NRF2 pathway, suggesting their potential as therapeutic agents for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
- Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Electronic address: zhoupanghu@whu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, H., Zhuang, H., & Zhou, P. (2026). PEGylated cerium oxide nanoparticles alleviate osteoarthritis progression by inhibiting chondrocyte ferroptosis and maintaining cartilage homeostasis. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.178563
Vancouver
Li H, Zhuang H, Zhou P. PEGylated cerium oxide nanoparticles alleviate osteoarthritis progression by inhibiting chondrocyte ferroptosis and maintaining cartilage homeostasis. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2026.178563
BibTeX
@article{Li2026,
author = {Li, Huajie and Zhuang, Huangming and Zhou, Panghu},
title = {PEGylated cerium oxide nanoparticles alleviate osteoarthritis progression by inhibiting chondrocyte ferroptosis and maintaining cartilage homeostasis},
journal = {European Journal of Pharmacology},
year = {2026},
doi = {10.1016/j.ejphar.2026.178563}
}
EUVIMED